Papillomavirus Vaccine May Reduce Vulval And Vaginal Cancers
Filed in archive Drugs, Vaccines and Therapeutics on May 20, 2007
According to a recent study, a quadrivalent Human Papillomavirus (HPV) vaccine is effective in preventing high-grade vulval and vaginal lesions that can lead to cancers in those areas.
Vaccine efficacy varied from 71% in women previously exposed to the human papillomaviruses to 100% in those not previously exposed. Additionally, a 49% reduction in all high-grade vulval and vaginal lesions, irrespective of casual HPV type, was seen in the intention-to-treat population of sexually active young women
The study has been published in this week's issue of The Lancet.
Soutce: Medical News Today
Tags: HPV cervical cancer papillomavirus gardasil vaginal+cancer biotech center+dubai
Vote for Papillomavirus Vaccine May Reduce Vulval And Vaginal Cancers:
|
Rating: 7.00 out of 4 vote(s) cast.
|
Response from:
Trusted.MD Network
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells